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ABSTRACT 
Objective: To synthesize, characterize and evaluate starch valerate as a superdisintegrant in the formulation of aceclofenac fast dissolving tablets 
by employing 23 factorial design. 
Methods: Starch valerate was synthesized and its physical and micromeritic properties were performed to evaluate it. The fast dissolving tablet of 
aceclofenac was prepared by employing starch valerate as a superdisintegrant in different proportions in each case by direct compression method  
using 23 factorial design for evaluation of tablet parameters like disintegration and dissolution efficiency in 5 min. 
Results: The starch valerate prepared was found to be fine, amorphous and free flowing. Starch valerate exhibited good swelling in water with 
swelling index (125.2%). The study of starch valerate was shown by fourier transform infrared spectra (FTIR). The drug content (200±5%), 
hardness (3.5–4 kg/sq. cm), and friability (<0.15%) has been effective with regard to all the formulated fast dissolving tablets employing starch 
valerate. The disintegration time of all the formulated tablets was found to be in the range of 14±0.04 to 25.7±0.02 sec. The optimized 
formulation F4 had the least disintegration time i.e., 12.8±0.02 sec. The wetting time of the tablets was found to be in the range of 76±0.21 to 
217±0.17s. The In vitro wetting time was less (i.e., 28±0.02s) in optimized formulation F4. The water absorption ratio of the formulated tablets 
was found to be in the range of 46±0.12 to 100±0.27%. The percent drug dissolved in the optimized formulation F8 was found to be 99.93% in 5 
min. 
Conclusion: Starch valerate, when combined with sodium starch glycolate, croscarmellose sodium, with aceclofenac, was found to be an effective 
super disintegrant which improved the dissolution efficiency and could therefore be used in the formulation of quick dissolvi ng tablets to provide 
immediate release of the contained drug within 5 min. 
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INTRODUCTION 
A numerous developments have been done in different dosage forms 
from ages and the most popular solid dosage forms were being 
tablets and capsules [1]. A lot of research was being done from many 
years in order to acquire many drugs to today’s world and among 
them the fast disintegrating tablets were chosen to make available 
over the counter as it avoids the swallowing problems and were first 
developed in the late 1970s as an alternative to conventional dosage 
forms [2] due to greater bioavailability [3]. Fast dissolving tablets 
were the dosage forms that disintegrate quickly so to release the 
drug, disperse and dissolve when placed on tongue [4], with the aid 
of superdisintegrant. Thus these formulations became an alternative 
dosage form to geriatrics, paediatrics and also to those people who 
were bedridden, mentally unwell, fear of swallowing. 
United States Food and Drug Administration (USFDA) outlined them 
as “A solid dose type containing a medicative substance or active 
ingredient that disintegrate quickly sometimes in a matter of 
seconds once placed upon the tongue” [5]. Fast dissolving tablets 
may also be known as mouth dissolving tablets, rapid dissolving, 
melt-in mouth tablets, or dispersible tablets, quick disintegrating 
tablets [6]. 
Aceclofenac was proved to be an effective NSAID with lower 
indication gastro-intestinal adverse effects and thus resulted in great 
compliance in treatment [7, 8], hence used in treatment of 
rheumatoid arthritis, osteoarthritis and ankylosing spondylitis, 
muscular skeletal studies, dental pain, postoperative pain, post-
traumatic pain, low back pain, and gynaecological pain etc. [9]. 
The main objective of this work was to formulate and characterize 
fast dissolving tablets of aceclofenac fast dissolving tablets 
employing starch valerate–a novel superdisintegrant prepared by 
modification of starch, sodium starch glycolate, crospovidone as 
superdisintegrants by using optimization techniques. A 23factorial 
design was applied to investigate the interaction effects of three 
variables i.e., starch valerate (A), sodium starch glycolate (B), 
crospovidone (C) in each case so as to find the formula with that of 
less disintegration time and more dissolution efficiency and to 
permit arbitrary selection of tablets with immediate release of drug 
within 5 min.  
MATERIALS AND METHODS 
Valeric acid was bought from Lotus Chemicals Ltd, Chennai. 
Methanol was gifted from Thermo Fischer chemicals Ltd, Mumbai. 
Potato starch, aceclofenac and crosspovidone were obtained from 
Yarrow chem. Products, Mumbai. Distilled water, Mannitol was 
purchased from Finar chemicals Ltd, Ahmedabad. Microcrystalline 
cellulose was purchased from Qualigens fine chemicals, Mumbai). 
Talc and Magnesium stearate were obtained from Molychem, 
Mumbai. 
Methods 
Preparation of starch valerate (A novel superdisintegrant) 
Potato starch was slurried using distilled water in a beaker and 
valeric acid was added to it, stirred continuously so that the potato 
slurry gets mixed properly. Then, the slurry was checked for pH and 
adjusted to 3.5 by adding 10M sodium hydroxide solution and was 
then conditioned for 16h at 60 °C. After conditioning, the unreacted 
valeric acid was drained and the solution remained was washed with 
distilled water and allowed to dry in the oven at 60 °C for around 2h. 
The dried solid mass was then sieved with sieve no. #120. The 
obtained fine powder was Starch Valerate [10]. 
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Characterization of starch valerate (Novel superdisintegrant): 
The prepared starch valerate was evaluated for the following;  
 Solubility : 
 
The solubility of starch valerate was tested in water, aqueous buffer solutions at different pH of 1,2,3,4,5,6 and 7. Also te sted 
in organic solvents such as alcohol, dichloromethane, chloroform, acetone, petroleum ether etc. [11]. 
 pH : Starch valerate was made into 1% w/v of dispersion or slurry and measured for pH, using ELICO pH Analyser [11]. 
 Viscosity : Starch valerate was made into 1% w/v of dispersion or slurry and measured its viscosity by using Ostwald’s viscometer [11]. 
 Swelling 
Index 
: Two 10 ml graduated tubes were taken; starch valerate was added into them till 1 ml marking. In one test tube distilled water 
and liquid paraffin into the other tube was poured and mixed well by shaking. The obtained dispersion was allowed to stand 
for 12h and readings were noted. The sediment volumes in the tubes were recorded. The swelling index was calculated as 






: A 7% w/v dispersions of starch as well starch valerate were prepared for evaluating the gelling property i.e., gelatinization by 
heating the dispersions in water bath at 100 °C for 30 min [11]. 
 Particle size : The prepared starch valerate was sieved by using standard sieves [11]. 
 Density : Density (gm/cc) was determined by liquid displacement method using benzene as the liquid [11]. 
 Bulk 
density 
: Two graduated cylinders were taken, starch in one and starch valerate in another were taken for determining bulk density 
(gm/cc) by tapping method [11].  
 Angle of 
repose 
: Placing a funnel at appropriate height with the help of a stand, starch as well as starch valerate was passed through the 
funnel, and markings were drawn, measured with scale and calculated [11].  
 Compressib
ility index 
: By placing the two graduated cylinders containing starch and starch valerate into Bulk density apparatus and allowed to tap 
for 100 times, readings were noted [11] and calculated by using the following equation;  
 
V0 = Initial volume of the powder 
V = Final volume of the powder 
 Melting 
Point 
: Some amount of starch valerate was taken into the capillary tube, then placed into the melting point apparatus to determine 
the melting point [11]. 
 FTIR : The spectra of starch valerate was recorded in FTIR i.e., Fourier Transform Infrared spectroscopy, on samples prepared in 
potassium bromide (KBr) disks by means of a hydrostatic press at 6-8 tons pressure. The scanning range was 500 to 4000 
cm-1using a BRUKER FT–IR, (Tokyo, Japan) [11].  
 Ester test : In a test tube, starch valerate (1 mg), ethanol (1 ml), (NaOH) sodium hydroxide (0.1 ml) were taken and as an indicator 
phenolphthalein was added. The colour change was observed [11]. 
 
Preparation of aceclofenac fast dissolving tablets 
By direct compression method using starch valerate, the aceclofenac 
quick dissolving tablets were prepared using 23 factorial designs in 
which 3 independent variables [3 superdisintegrants i.e. starch valerate 
(A), sodium starch glycolate (B), crospovidone (C)] and 5 dependent 
variables [percentage dissolved in 5 min, dissolution efficiency in 5 min, 
wetting time, water absorption ratio, disintegration time] were applied. 
Table 1, in which superdisintegrants were selected at 2 stages, i.e. higher 
and lower, shows the composition of the different formulations of 
aceclofenac rapid dissolving tablets. 5% concentration of starch 
itaconate (A), sodium starch glycolate (B) and crospovidone (C) at the 
higher level, and 0% concentration of starch velarate (A), sodium starch 
glycolate (B) and sodium starch glycolate (B),crospovidone (C) at lower 
level. Each ingredient was passed through the # 120 mesh sized screen 
before mixing for uniformity in particle size. Starch valerate, sodium 
starch glycolate, crospovidone, mannitol, and microcrystalline cellulose 
were precisely weighed and combined and added to aceclofenac using 
mortar and pestle. Finally, a powder mixture was applied with talc and 
magnesium stearate. Lastly, the mixed mixture was compressed by using 
eight station rotator (Presshakthi Machineries Pvt, Ltd., Ahmedabad, 
India) [12]. 
 
Table 1: Formulae of aceclofenac fast dissolving tablets employing starch valerate 
Ingredients (mg per tablet) F1 F2 F3 F4 F5 F6 F7 F8 
 Aceclofenac 100 100 100 100 100 100 100 100 
Starch valerate - 25 - 25 - 25 - 25 
Sodium Starch Glycolate - - 25 25 - - 25 25 
Crospovidone - - - - 25 25 25 25 
Mannitol 130 105 105 80 105 80 80 55 
Micro Crystalline Cellulose 250 250 250 250 250 250 250 250 
Talc 10 10 10 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 10 10 10 
Total Weight of the tablet 500 500 500 500 500 500 500 500 
 
Evaluation of aceclofenac fast dissolving tablets 
Hardness 
The strength required in a diametric manner to split the tablet is 
called tablet hardness. It is usually measured using the Monsanto 
hardness tester, which causes the strength to fall diametrically on 
the tablet with the aid of its built-in spring. This was expressed in 
terms of kg/cm2 [13]. 
Uniformity of weight 
For weight variation test to be done, 20 tablets were taken. The 
individual variation of tablet weight from the average weight of 20 
tablets was considered to be the weight variation [13]. 
Average weight of tablet % Deviation 
80 mg or less ±10 
More than 80 mg or less than 125 mg ±7.5 
125 mg or less  ±5 
Santosh et al. 
Int J App Pharm, Vol 13, Issue 4, 2021, 168-176 
170 
Friability 
The tablets were initially weighed and then put into the Roche 
friabilator for friability calculation, where the tablets were allowed 
to rotate for 4 min or up to 100 revolutions at 25 rpm. After removal 
from the friabilator, the tablets were weighed again and the 
percentage of weight loss was determined [13] using the formula 
below, 
 
Drug content uniformity 
10 tablets were weighed and powdered to determine the uniformity 
of the drug content. Powder equivalent to 10 mg of the medication, 
i.e., aceclofenac was extracted and filtered into a 7.4 phosphate 
buffer, whereby the aceclofenac content was determined by 
spectrophotometric absorption measurement at 274 nm after 
sufficient dilution with a 7.4 phosphate buffer and was measured as 
an average of three determinations [13]. 
Wetting time 
By taking a petri dish of about 10 cm in diameter and five tissue papers 
and an amaranth solution (water soluble dye-for color), the wetting 
time can be determined. The tissue paper was put in the petri dish and 
about 10 ml of amaranth solution was poured into it, so that the color 
solution would be absorbed by the tissue paper. Then, the tablets were 
placed individually on the surface of the tissue paper and the time 
taken by the tablet to absorb the color was noted [13]. 
Water absorption ratio 
The same wetting time method was followed to find out the water 
absorption ratio, but after the tablet absorbs the color water, the 




W a-weight of tablet after water absorption 
Wb-weight of tablet before water absorption 
In–vitro disintegration time 
The prepared tablets were placed into the disintegration testing 
apparatus (LABINDIA) containing 900 ml of the 7.4 phosphate as the 
disintegration media, maintained at a temperature range of 37±0.2 
°C. The time taken by the tablet for complete disintegration with no 
solid, palatable mass in the apparatus was recorded [13]. 
In–vitro dissolution studies 
An 8–stage dissolution apparatus (Electro-Lab, TDT-08L) was used 
to study the dissolution of aceclofenac fast dissolving tablets. Before 
dropping the tablets into the apparatus for testing, the buffer (7.4 
pH-phosphate buffer) of 900 ml was poured into each basket and it 
should be reach with the temperature required i.e., 37±0.5 °C, 
paddles should be fitted and rpm was set to 50rpm. Once the 
apparatus was all set to use, the tablets were dropped, at pre-
determined time intervals the samples of 5 ml were collected, 
filtered, diluted if required and assayed at 274 nm using Shimadzu 
UV-1800 UV/Visible Scanning Spectrophotometer. Cumulative 
percentage release was calculated using standard absorbance from 
the calibration curve. All the dissolution experiments were 
conducted in triplicate (n = 3) [13]. 
Factorial design 
The present study used factorial design to evaluate the individual 
and combined effects. The formulation contains three 
superdisintegrants and therefore, to evaluate these effects a 
23factorial design was applied. The parameters of fast dissolving 
tablets (disintegration and dissolution efficiency in 5 min) were 
analysed as per ANOVA of 23 factorial design. Contour plots and 
surface plots were drawn with the help of Design Expert 7.11 
version software. Based on the results of statistical analysis, the 
optimum formulation was selected. 
Comparison of optimized formulation with marketed formulation 
The optimized formulation was compared with marketed 
formulation (ACECLO) containing 100 mg of aceclofenac after 
removal of film coating. 
Label claim of marketed formulation 
Each ACECLO film coated tablet of 100 mg contains titanium dioxide 
as colour of the tablet to protect from light, moisture and 
temperature. The tablets used for the experiment were 
manufactured by ARISTO Pharmaceuticals Pvt. Ltd., Makhnumajra 
village, Baddi district, Himachal Pradesh–173205 bearing 
M/736/2016 as manufacturing license number that belongs to 
5340K028 batch. The tablets manufactured date was 10/2019 and 
expiry date was 09/2020. 
RESULTS AND DISCUSSION 
The prepared starch valerate was found to be fine, amorphous and 
free-flowing powder. It was insoluble in water, aqueous buffers (pH 
1,2,3,4,5,6 and 7) and also in organic solvents (methanol, petroleum 
ether, dichloromethane, and chloroform) which were tested with 1% 
w/v of starch valerate dispersion. Also, its physical and micromeritic 
properties were analysed, indicated good flow and compressibility 
properties which were needed for a solid dosage form to 
manufacture and results were summarized in table 2.  
Starch valerate had exhibited good swelling property in water when 
compared to swelling in light liquid paraffin. The swelling index was 
125.2%. The density of starch valerate was found to be 0.9908 
gm/cc. The FTIR spectra of starch and starch valerate were shown in 
fig. 1 and 2. The presence of peaks absorption at 1639.97 cm-1, which 
was a characteristic peak of ester, so from FTIR studies it was 
concluded that starch valerate (ester) was formed when starch was 
allowed to react with valeric acid.  
The test for ester was performed and disappearance of pink colour 
confirmed the presence of ester i.e., starch valerate. When starch 
valerate was taken into capillary tube, for testing its melting point 
using melting point apparatus, it was found to melt at 182.6 °C. 
  
Table 2: Physical and micromeritic properties of prepared novel superdisintegrant-starch valerate 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents that were tested. 
pH  3.48±0.02 
Viscosity 1.068 0.008 cps 
Swelling index (S. I) 125.2% 
Gelling property Np gelation of starch valerate particles, whereas starch particles formed gel.  
Particle size 5.82±2.124μm 
Density 0.9908±0.0004 gm/cc 
Bulk density 0.52±0.03 gm/cc 
Angle of repose 13.39 ° (good) 
Compressibility index (CI) 25±0.01 
Melting point 182.6 °C 
*SD Standard Deviation from mean, n=3, mean±SD.  
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Fig. 1: FTIR spectra of potato starch 
 



















































































































































Fig. 2: FTIR spectra of starch valerate 
 
Evaluation of tablets 
Hardness 
The tablet hardness of the optimized formulation as well as 
marketed were in the range of 3.5-4 kg/cm2, indicates good strength 
with a capability to resist its physical and pre-functionary stress 
conditions during travelling and handling. The harness of tablet was 
greater when compared with the hardness of the tablets i. e 1.23-
1.63 kg/cm2 prepared by Vivek Dave et al. [14]. 
Friability 
By performing friability test to all the optimized formulations as well 
as marketed formulation, the weight loss was found to be less than 
0.15% indicating good mechanical resistance of tablets. Thus, it was 
proved that tablets could withstand the pressure, mechanical shocks 
during handling, transportation, storage and manufacturing processes. 
The friability loss was relatively less when compared with the friability 
of tablets i. e 0.15-0.72% prepared by C. Mallikarjuna Setty, et al. [15] 
Drug content 
The prepared fast dissolving tablets containing aceclofenac claimed 
within 200±5 % of that of the label which was higher in comparison 
to the drug content of tablets i. e 95±5% prepared by Keshav R. 
Deshmukh, et al. [16]. 
Wetting time and water absorption ratio 
Wetting time and water absorption ratio of tablets formulated as 
well as marketed resulted to be within the limits that were 
prescribed and obeyed the criteria of fast dissolving tablets. The 
wetting time at initial and final times were depicted in the fig. 3. The 
optimized formulation F-8 had shown less wetting time i. e 25±0.17 
seconds when compared to other formulations and marketed 
formulation which was less when compared to the wetting of tablets 
that ranged from 29.62±0.87 to 32.66±1.87 seconds which were 
prepared by Jyotsana Madan, et al. [17]. The water absorption ratio 
was found to be 100±0.27% which was relatively more when 
compared to the water absorption ratio of tablets i. e 74.48% 
prepared by Kalpesh Gaur A [18]. 
In–vitro disintegration time 
As mentioned in the table 3, the disintegration time of all formulated 
tablets and marketed formulation was laid between 14.0±0.04 to 
25.7±0.02 seconds which was comparatively lesser the 
disintegration time of tablets i. e 18-40 seconds prepared by Anas 
Bahnassi et al. [19]. 
In–vitro dissolution studies 
From in vitro dissolution studies of fast dissolving tablets containing 
aceclofenac employing starch valerate, their profile was shown in fig. 
4(a) and 4(b) and the optimized formulation with marketed 
formulation dissolution profile was compared as given in table 4 and 
5. The dissolution parameters of all the formulations i.e., F-1 to F-8 
and marketed formulations were given in table 4, whereas the 
optimized formulation i.e., F-8 had shown more PD5 (percent 
dissolved in 5 min) which contains 5% starch valerate, sodium 
starch glycolate and crospovidone was found to be 99.93±0.11% 
which was more when compared to the percent dissolved of tablets 
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i. e 99.5% which were prepared by Garala Kevin C et al. [20]. Even 
DE5% (dissolution efficiency in 5 min) was shown more in the 
optimized formulation, F-8. 
The PD5 and DE5% reveals that tablets were effective at 5 % starch 
valerate, 5 % sodium starch glycolate and 5% crospovidone, when 
the formulations were made by direct compression using these 
superdisintegrants. The number of folds in DE5% was given in the 
table 4. Therefore, from the results it was concluded that starch 
valerate (novel superdisintegrant) could be used as 
superdisintegrant in the formulation of fast dissolving tablets of 
aceclofenac.
 
Table 3: Comparison of physical properties: Hardness, friability, drug content, disintegration time, wetting time, water absorption ratio of 












ratio (%) n±SD 
F1 3.6±0.01 0.11±0.013 96.12±0.71 25.7±0.02 42±0.02 46±0.12 
F2 3.5±0.03 0.12±0.015 97.48±0.79 18±0.03 29±0.12 100±0.18 
F3 3.6±0.01 0.13±0.012 98.10±0.63 19±0. 02 27±0.09 83.3±0.16 
F4 3.7±0.04 0.12±0.014 98.32±0.55 12.8±0. 02 28±0.02 100±0.15 
F5 3.6±0.03 0.12±0.012 99.23±0.56 14±0.01 22±0.21 82.1±0.21 
F6 3.9±0.01 0.13±0.012 99.45±0.18 17±0.02 25±0.09 72±0.12 
F7 3.8±0.02 0.11±0.014 99.56±0.57 13±0. 01 28±0.15 89±0.15 
F8 3.8±0.04 0.11±0.013 99.79±0.11 15±0.02 25±0.17 100±0.27 
Marketed 
formulation 
3.9±0.01 0.12±0.012 99.12±0.11 14±0.04 23±0.19 75±0.27 
*SD Standard Deviation from mean, n=3, mean±SD. 
 
Fig. 3: Wetting times of aceclofenac fast dissolving tablets (employing starch valerate) 
F-1 of Aceclofenac fast dissolving tablet F-2 of Aceclofenac fast dissolving tablet 
    
At time = 0 sec At time = 42 sec At time = 0 sec At time = 29 sec 
F-3 of Aceclofenac fast dissolving tablet F-4 of Aceclofenac fast dissolving tablet 
    
At time = 0 sec At time = 27 sec At time = 0 sec At time = 28 sec 
F-5 of Aceclofenac fast dissolving tablet F-6 of Aceclofenac fast dissolving tablet 
    
At time = 0 sec At time = 22 sec At time = 0 sec At time = 25 sec 
F-7 of Aceclofenac fast dissolving tablet F-8 of Aceclofenac fast dissolving tablet 
    
At time = 0 sec At time = 28 sec At time = 0 sec At time = 25 sec 
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Table 4: Comparison of dissolution parameters of aceclofenac fast dissolving tablets formulated employing starch valerate and other 
known superdisintegrants with marketed formulation 
Time (min) F-1 F-2 F-3 F-4 F-5 F-6 F-7 F-8 Marketed 
formulation 
PD5 04.94±0.12 25.98±013 27.07±0.17 49.20±0.18 60.49±0.15 63.26±0.12 51.55±0.14 99.93±0.11 75.20±0.13 
DE5 % 4.4±0.11 21.8±0.09 25.2±0.05 49.2±0.12 57.8±0.14 64.4±0.08 84.2±0.13 95.4±0.01 28.32±0.12 
No of folds 
increase in DE5 % 
- 4.95 5.72 11.18 13.13 14.63 10.95 21.68 --- 
*SD Standard Deviation from mean, n = 3, mean±SD, PD5-Percent dissolved in 5 min, DE5%-Dissolution efficiency in 5 min,  
 
 
Fig. 4 (a): Dissolution profiles of aceclofenac fast dissolving tablets prepared employing starch valerate (F1-F4) 
 
 
Fig. 4(b): Dissolution profiles of aceclofenac fast dissolving tablets prepared employing starch valerate (F5-F8) 
 
Table 5: Comparison of aceclofenac percent dissolved from dissolving tablets employing starch valerate with marketed formulation 
Time 
(min) 
F1 F2 F3 F4 F5 F6 F7 F8 Marketed 
formulation 
5 04.94±0.12 25.98±0.13 27.07±0.17 49.20±0.18 60.49±0.15 63.26±0.12 51.55±0.14 99.93±0.11 75.20±0.13 
10 07.26±0.11 35.78±0.12 42.18±0.10 97.30±0.15 82.69±0.10 89.65±0.11 96.48±0.12 --- 88.21±0.10 
15 13.69±0.10 75.53±0.11 99.00±0.02 --- 99.74±0.08 99.94±0.02 --- --- 99.32±0.24 
30 28.11±0.20 99.42±0.09 --- --- --- --- --- --- --- 
45 29.18±0.18 --- --- --- --- --- --- --- --- 
60 30.89±0.12 --- --- --- --- --- --- --- --- 
*SD Standard Deviation from mean, n=3, mean±SD. 
 
The disintegration time and dissolution efficiency in 10 min 
indicates that the dependant variables strongly depend on the 
independent variables.  
The fitted equations relating the disintegration time and dissolution 
efficiency by the end of 5 min to the transform factors were shown 
in the following equations, 
Disintegration time =+45.88+3.38A–5.63B–5.13C+0.63AB–0.37AC–
2.12BC+1.12ABC. (R2= 1.000)  
Dissolution efficiency in 5 min =+28.76+11.96A+10.26B+ 
16.34+9.01AB+6.64 AC+4.39BC+8.04. (R2= 1.000) 
The value of the R2 indicates the good fit. The polynomial equations 
can be used to draw a conclusion after considering the magnitude of 
coefficient and the mathematical sign it carries (Positive or 
Negative). Once the polynomial equation, which relate the levels of 
each factor and their corresponding interactions with disintegration 
time and percent release in 5 min, the surface response curves and 
contour plots were constructed using software. 
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A) Surface plot       B) Counter plot 




(A) Surface plot      B) Contour plot 




(A) Surface plot     B) Counter plot 
Fig. 5.3: A. Surface plot, B. Contour plot of Aceclofenac fast dissolving tablets (Effect of Sodium starch glycolate and Crospovidone on 
disintegration time) 
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A) Surface plot     B) Counter plot 
Fig. 5.4: A. Surface plot, B. Contour plot of Aceclofenac fast dissolving tablets (Effect of Sodium starch glycolate and Crospovidone on 
dissolution efficiency in 5 min) 
 
 
A) Surface plot       B) Counter plot 
Fig. 5.5: A. Surface plot, B. Contour plot of Aceclofenac fast dissolving tablets (Effect of Starch Valerate and Crospovidone on dissolution 
efficiency in 5 min) 
 
 
A) Surface plot      B) Counter plot 
Fig. 5.6: A. Surface plot, B. Contour plot of Aceclofenac fast dissolving tablets (Effect of Sodium starch glycolate and Crospovidone on 
dissolution efficiency in 5 min) 
  
The response surface plots and contour plots reveal that, with the 
increase in concentration of starch valerate (A), sodium starch 
glycolate (B) and crospovidone (C), the disintegration time 
decreases. The effects of A and B on disintegration time were shown 
in fig 5.3. The contour plots were found to be linear up to certain 
extent, there after they were non-linear. From the contour plot in fig. 
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5.3, it was determined that a less disintegration time can be obtained 
with A-level range between 3.75 to 5% and B level range from 3.75 
to 5% The effects of B and C were shown in fig. 5.4, where the 
contour plots were found to be linear indicating linear relationship 
between B and C. From the contour plots, the linearity was found 
indicating the linear relationship between B and C. Also, it was 
determined from the contour plot (fig. 5.4) that, the less 
disintegration time was obtained with B-level in between 3.75 to 5% 
and C-level range from 3.75 to 5% The effects of A and C were 
depicted in fig. 6.5, the contour plots were almost found to be linear 
indicating a linear relationship between A and C. From the contour 
plot, it was determined that, less disintegration time was obtained 
with A-level in between 3.75 to 5% and C-level between 3.75 to 5%. 
From this we can conclude that, less disintegration time can be 
achieved when the factor-A was used in the concentration range 
from 3.75 to 5% B and C-levels in the range of 3.75 to 5% of the total 
weight of the tablet.  
The response surface plots and contour plots reveal that, with the 
increase in concentration of starch valerate (A), sodium starch 
glycolate (B) and crospovidone (C), the dissolution efficiency in 5 
min increases. The effect of A and B on dissolution efficiency in 5 
min were shown in fig. 5.6, the contour plots were found to linear to 
the maximum extent. From the contour plot, it was determined that, 
more dissolution efficiency can be obtained with A-level range at 
3.75 to 5% and B-level range 3.75 to 5%. The effects of B and C were 
depicted in fig. 5.7, where the contour plots were found to be linear, 
indicating the linear relationship between B and C. From the contour 
plot, it was determined that, more dissolution efficiency can be 
obtained with B-level range between 3.75 to 5%. The effects of A and 
C were shown in fig. 5.8, where the contour plots were found to be 
linear, indicating the linear relationship between A and C. From the 
contour plot, it was determined that, more dissolution efficiency in 5 
min can be obtained in A-level range between 3.75 to 5% and C-level 
in a range between 3.75 to 5%. 
CONCLUSION 
The prepared starch valerate was found to be fine, amorphous and 
free-flowing powder. Also, its physical and micromeritic properties 
were analysed indicated good flow and compressibility properties 
which were needed for a solid dosage form to manufacture. Potato 
starch was amorphous in nature whereas the prepared starch 
valerate was amorphous, fulfilling the aspects of superdisintegrant 
characteristics, hence starch valerate, a novel superdisintegrant can 
be used as a superdisintegrant in the formulation of fast dissolving 
tablets. 
From the above data, the superdisintegrants that to be used in fast 
dissolving tablets to have less disintegration time and more 
dissolution efficiency in 5 min were; factor-A i.e., Starch Valerate 5%, 
factor-B i.e., Sodium starch glycolate 5% and factor-C i.e., 
Crospovidone were found to be the ideal concentrations to 
formulate into fast dissolving tablets. 
ABBREVIATION 
M–Molar, NaOH–Sodium Hydroxide, °C-Degree Centigrade, #-
Number, pH-Potential of hydrogen, ml-millilitre, S. I-Swelling Index, 
W/V–Weight/Volume, LBD-Loose bulk density, TBD-Tapped bulk 
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